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Comparison of Body Mass Index with Type 1 Diabetes in 15-30 Years Onset Age among the Chronological
Periods of Onset and Investigation of the Clinical Factors Affecting Body Weight Change
Sari HOSHINA, Junnosuke MIURA and Yasuko UCHIGATA
Diabetes Center, Tokyo Women’s Medical University School of Medicine
Objective: This study compared the maximum body mass index (maxBMI) of patients (onset age: 15-30
years) before and at the onset of type 1 diabetes (T1D) based on the decade of their disease onset (1970-2009). In
addition, risk factors for BMI changes after T1D onset were investigated.
Subjects and Methods: A total of 431 patients (157 men) who underwent medical examinations from 1970 to
2009 and developed T1D at 15-30 years of age were included. The patients were classified into 4 groups based on
the decade of their T1D onset (group I: 1970-1979; group II: 1980-1989; group III: 1990-1999; and group IV: 2000-
2009). BMI and HbA1c levels were measured after the administration of the patient’s daily required insulin dose
over a period of 5 years after T1D onset. Family history of diabetes and the patient’s maxBMI were also com-
pared. Study A compared patients with maxBMI of22 kg/m2 and＜22 kg/m2. Study B compared sHLA (－) pa-
tients with sHLA (＋) patients who had T1D susceptibility based on a human leukocyte antigen (HLA) haplotype
of DRB1*04:05-DQB1*04:01.
Results: In all, 0 % of men in group I, 21.6 % of men in group II, 22.0 % of men in group III, and 13.5 % of men
in group IV were obese (i.e., maxBMI25 kg/m2); the proportion of lean men (BMI＜18.5 kg/m2) was similar in
all groups. Furthermore, 0 % of women in group I, 13.2 % of women in group II, 13.4 % of women in group III, and
14.7 % of women in group IV were obese (i.e., maxBMI 25 kg/m2); the proportion of lean women (BMI ＜18.5
kg/m2) was similar in all groups. In study A, BMI was significantly higher for patients who had an maxBMI of
22 kg/m2 for 5 years after T1D onset. In study B, the sHLA (＋) group had a smaller increase in BMI after T1D
onset compared with the sHLA (－) group.
Conclusion: Patients with T1D remained comparatively lean at disease onset over the 40-year period of our
study. Moreover, sHLA (＋) patients were not likely to have an increased BMI after T1D onset when compared
with sHLA (－) patients.
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の測定方法は，抗 GAD抗体，抗 IA-2抗体は RIA
法，膵島自己抗体は蛍光抗体法を用い，それぞれカッ
トオフ値を 1.5 U/ml，0.4 U/ml，1.25 JDF UNITS
とした．肥満度は全例 BMIを算出し，日本肥満学会















Fig.　1　Maximum body mass index (maxBMI) before the onset of type 1 diabetes for 4 
time periods (1970-1979, 1980-1989, 1990-1999, and 2000-2009)
Disease onset per 10 years is presented on the X-axis. Patients were classified into 3 
groups based on maxBMI according to the diagnostic criteria for obesity by the Japan 
Society for the Study of Obesity: lean, ＜18.5 kg/m2; moderate, ＞＿18.5 and ＜25.0 kg/m2; 
and obese, ＞＿25 kg/m2. The gray area indicates the lean group, the white area indicates 
the moderate group, and the black area indicates the obese group. Analyses 1 vs 2, 3, 
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Table　1　Baseline characteristics according to onset years
① 1970-1979 ② 1980-1989 ③ 1990-1999 ④ 2000-2009
Male
N 18 51 50 37
Onset age (years) 22±4 22±4 23±4 22±4
BMI at onset (kg/m2) 17.9±2.1 18.6±2.2 18.9±2.2 18.5±2.1
HbA1c at onset (%) － 9.9±2.2 13.4±4.0 11.9±3.1
maxBMI (kg/m2) 20.7±1.8 22.1±3.1 23.2±3.5＊ 21.9±3.3
Age at max BMI (years) 21±4 21±4 21±4 19±3
Family history of diabetes (%) 38.9 21.6 16.0 18.9
Female
N 33 76 97 68
Onset age (years) 22±4 21±4 22±4 23±4
BMI at onset (kg/m2) 17.8±1.7 18.4±3.2 18.1±2.9 18.1±1.9
HbA1c at onset (%) － 13.7±3.7 12.7±2.9 12.5±2.6
maxBMI (kg/m2) 21.5±1.8 22.0±3.9 22.0±3.4 21.8±3.4
Age at max BMI (years) 20±4 20±5 20±4 20±4
Family history of diabetes (%) 30.3 19.7 23.7 19.1









Fig.　2　BMI at the onset of type 1 diabetes for 4 time periods (1970-1979, 1980-1989, 1990-
1999, and 2000-2009)
Disease onset per 10 years is presented on the X-axis. Patients were classified into 3 
groups based on maxBMI according to the diagnostic criteria for obesity by the Japan 
Society for the Study of Obesity: lean, ＜18.5 kg/m2; moderate, ＞＿18.5 and ＜25.0 kg/m2; 
and obese, ＞＿25 kg/m2. The gray area indicates the lean group, the white area indicates 
the moderate group, and the black area indicates the obese group. Analyses 1 vs 2, 3, 
and 4 were performed using Fisher’s exact probability test.
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Table　2　Baseline characteristics according to maxBMI before onset of diabetes
lean moderate obesity p (lean vs obesity) 
Male
N 10 119 27
Onset age (years) 18±3 22±4 23±3 0.0013
BMI at onset (kg/m2) 15.5±1.0 18.3±1.8 21.1±1.9 ＜0.0001
HbA1c at onset (%) 10.5±2.4 11.4±3.5 12.7±3.0 0.3388
maxBMI (kg/m2) 17.7±0.8 22.4±1.8 27.7±2.2 ＜0.0001
Age at max BMI (years) 18±3 21±4 21±4 0.0262
Diabetes family history (%) 30.0 17.1 37.0 0.6881
Initial Insulin dose (U/kg/day) 0.46 (0.34-0.93) 0.38 (0.19-0.68) 0.45 (0.27-0.74) 0.7520
Female
N 28 213 33
Onset age (years) 21±4 22±4 23±5 0.1840
BMI at onset (kg/m2) 15.7±1.1 18.0±1.8 21.6±4.0 ＜0.0001
HbA1c at onset (%) 13.5±2.0 12.0±3.1 12.9±2.1 0.5843
maxBMI (kg/m2) 17.6±1.1 21.4±1.5 28.8±3.8 ＜0.0001
Age at max BMI (years) 21±4 20±5 20±4 0.3890
Diabetes family history (%) 7.1 24.8 21.2 0.1116
Initial Insulin dose (U/kg/day) 0.47 (0.20-0.67) 0.40 (0.11-0.61) 0.45 (0.22-0.61) 0.8907








統計解析は SAS 9.2，JMP pro 12.0 software（SAS




Fig.　3　Changes in BMI (kg/m2) over the 5 years after type 1 diabetes onset for men (A) 
and women (B)
Black squares indicate a maximum BMI (maxBMI) of ＞＿22 kg/m2. Gray circles indicate 
an maxBMI of ＜22 kg/m2. Dots indicate the average BMI. Upper and lower horizontal 
bars indicate standard deviation. ＊Onset: 60 months. †6 months vs 60 months; p＜0.05. 
BMI change rate (%) is shown from disease onset to 5 years later and from 6 months af-
ter the onset to 5 years later for men (C) and women (D). In these box plots, a line within 
a box indicates the median. The upper and lower squares within the box include the 
quartiles of the points. The upper and lower horizontal bars indicate the maximum and 
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Pearson’s rank correlation testを使用し，インスリ
ン投与量，BMIの変化については正規分布では


























Fig.　4　Changes in insulin dose (U/kg/day) from the onset of type 1 diabetes to 5 years 
later for men (A) and women (B)
Black squares indicate a maximum BMI (maxBMI) of ＞＿22 kg/m2. Gray circles indicate 
an maxBMI of ＜22 kg/m2. Dots indicate the median insulin dose. Upper and lower hori-
zontal bars indicate the quartiles of the points. ＊Onset vs 60 months. †6 months vs 60 
months; p＜0.05. Change of insulin dose (U/kg/day) from the onset of type 1 diabetes 
to 5 years later and from 6 months after disease onset to 5 years later for men (C) and 
women (D). A line within the box indicates the median. Upper and lower squares within 
the box include the quartiles of the points. Upper and lower horizontal bars indicate the 
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発症 6か月後の BMIに比較し，5年後の BMIも有
意に増加した（Fig. 3A，B）．さらに，発症時から発








Fig.　5　Change in HbA1c levels (%) from the onset 
of type 1 diabetes to 5 years later for men (A) and 
women (B)
Black squares indicate a maximum BMI (maxBMI) 
of ＞＿22 kg/m2. Gray circles indicate an maxBMI of 
＜22 kg/m2. Dots indicate the average value. Up-
per and lower horizontal bars indicate the standard 



























































































ら 4％とやや増加，20歳以上で 7％から 4％とやや









Fig.　6　BMI change rate (%) by HLA from the onset of type 1 diabetes to 5 years later (A) 
and from 6 months after disease onset to 5 years later (B)
In the middle part of the figure, a maximum BMI (maxBMI) of ＜25 kg/m2 is shown. The 
lower part of the figure shows an maxBMI of ＜22 kg/m2. A line within the box indicates 
the median. Upper and lower squares within the box include the quartiles of the points. 
Data were compared using the Student’s t-test. Three patients were homozygous for HLA 
DR4＋DQ4＋ haplotype. HLA DR4－DQ4－ group was divided into 3 types, HLA DR4＋
DQ4－ : 1 patient, HLA DR4－DQ4＋ : no patient, HLA DR4－DQ4－ : 16 patients. Eight 
patients were homozygous for HLA DR9＋DQ3＋haplotype and 4 patients were hetero-







































(n)  11 12 (n)  9 12
(n)  16 17
(n)  21 17 (n)  19 16
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